Evidence map›Paper›PMID 40182990›Full record

ArticleFrontiers in bioengineering and biotechnology2025

Niagara

Yang Yang, Hao Yan, Huang Xianli, Ran Maoxia, Liu Chen, Liu Zhuang, Chen Yu, Zhang Ling

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yang YangCollege of Architecture and Environment, Sichuan University, Chengdu, Sichuan, China.
Hao YanDepartment of Nephrology, Zigong First People's Hospital, Zigong, Sichuan, China.
Huang XianliDepartment of Nephrology, Zigong First People's Hospital, Zigong, Sichuan, China.
Ran MaoxiaDepartment of Nephrology, Dazhou Central Hospital, Dazhou, China.
Liu ChenDepartment of Nephrology, Kidney Research Institute, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
Liu ZhuangCollege of Chemical Engineering, Sichuan University, Chengdu, Sichuan, China.
Chen YuCollege of Architecture and Environment, Sichuan University, Chengdu, Sichuan, China.
Zhang LingDepartment of Nephrology, Kidney Research Institute, West China Hospital of Sichuan University, Chengdu, Sichuan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hemodialysis is an important means to sustain life in patients with end-stage renal disease In China, more than 100,000 hemodialysis patients need to have a catheter fitted at least once (temporary or long term) for dialysis. Despite the widespread use and low cost of HD catheters, they remain prone to critical issues such as high thrombosis rates, infections, and dysfunction. This study addresses the persistent challenge of thrombosis formation in dialysis catheters by investigating the incorporation of helical flow inducers, a strategy inspired by the naturally occurring helical blood flow in arterial systems. In this research, helical flow inducers with varying pitch and diameter were integrated into the widely used Niagara

Indexed as

catheterhelical flowhemodynamiclocal normalized helicityresidence time

Identifiers

PMID40182990
PMCPMC11966438

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.